Sold out
Parameters
- 168 pages
- 6 hours of reading
More about the book
With a minimum of side effects, low toxicity in overdose and a broad range of clinical applications, selective serotonin re-uptake inhibitors have found widespread and increasing use in psychiatry worldwide. Here is the most comprehensive reference source available on these important drugs. Beginning with examinations of the drugs' pharmacology their effects on serotonergic function and the central role of serotonin in many psychiatric disorders, the book moves on to reviews of clinical trials in many psychiatric conditions. Finally, an important chapter discusses clinical issues in the use of these agents.
Book purchase
Perspectives in Psychiatry - 1: Selective Serotonin Re-Uptake Inhibitors, John Preston Feighner, W. F. Boyer
- Language
- Released
- 1991
- product-detail.submit-box.info.binding
- (Hardcover)
We’ll email you as soon as we track it down.
Payment methods
No one has rated yet.
- Title
- Perspectives in Psychiatry - 1: Selective Serotonin Re-Uptake Inhibitors
- Subtitle
- The Clinical Use of Citalopram, Fluoxetine, Fluvoxamine, Paroxetine, and Sertraline
- Language
- English
- Authors
- John Preston Feighner, W. F. Boyer
- Publisher
- Wiley
- Released
- 1991
- Format
- Hardcover
- Pages
- 168
- ISBN10
- 0471928909
- ISBN13
- 9780471928904
- Series
- Tags
- Non-Fiction, Social Sciences, Health & Medicine, Psychology, Mental Health, Psychiatry, Pharmacology
- Description
- With a minimum of side effects, low toxicity in overdose and a broad range of clinical applications, selective serotonin re-uptake inhibitors have found widespread and increasing use in psychiatry worldwide. Here is the most comprehensive reference source available on these important drugs. Beginning with examinations of the drugs' pharmacology their effects on serotonergic function and the central role of serotonin in many psychiatric disorders, the book moves on to reviews of clinical trials in many psychiatric conditions. Finally, an important chapter discusses clinical issues in the use of these agents.